Ultrasound Needle Guidance Improves Spasticity Service At The Royal Berkshire

The image quality and ease of use of SonoSite's NanoMaxx® hand-carried ultrasound system are allowing paediatricians at the Royal Berkshire NHS Foundation Trust in Reading to provide precisely targeted intramuscular injections for the relief of spasticity in children with cerebral palsy. End Quote

(1888PressRelease) September 28, 2012 - Dr Rosalind Jefferson, Consultant Paediatrician at the Trust, explained: "We have been interested in ultrasound needle guidance for the focal treatment of spasticity in children since 2005, as this improves accuracy and reliability in administering botulinum toxin injections. Children with cerebral palsy may have quite 'thin' muscles, making it very easy to inject too deeply using palpation alone. The use of ultrasound to guide these injections is highly beneficial, particularly for the upper limbs, where the muscles are not easily identified without ultrasound or EMG. Ultrasound is also much less uncomfortable for the children than EMG."

"We originally borrowed a portable ultrasound system from the Neonatal Unit for this service, but the instrument was only available intermittently, and so we looked at purchasing our own handcarried system. The NanoMaxx combined the image quality we required with exceptional ease of use, as well as being very competitively priced, providing clear images with very few adjustments thanks to the one touch optimisation feature. We have two linear transducers - including one designed specifically for imaging small parts, such as the muscles around the thumb - giving us the flexibility to perform a wide range of injections quickly and efficiently."

For more information about SonoSite products, please contact:
SonoSite UK, Alexander House, 40A Wilbury Way, Hitchin SG4 0AP
T +44 (0)1462 444 800, F +44 (0)1462 444 801
ukresponse ( @ ) sonosite dot com www dot sonosite dot com

About SonoSite
SonoSite, Inc. (www.sonosite.com), a subsidiary of FUJIFILM, is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

SonoSite, Ltd., a wholly owned subsidiary of SonoSite, Inc. based in Hitchin, Hertfordshire, oversees a direct sales distribution network in the UK and provides sales and marketing support for SonoSite's European offices.

###

space

Other Related Press Releases